证券代码：688067 证券简称：爱威科技 公告编号： 2025-046 爱威科技股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： （二） 会议召开地点：上海证券交易所上证路演中心 会议召开时间：2025 年 11 月 24 日 （星期一） 15:00-16:00 会议召开地点：上海证券交易所上证路演中心（网址：https://roadshow.ssei nfo.com/） 会议召开方式：上证路演中心网络互动 （三） 会议召开方式：上证路演中心网络互动 三、 参加人员 董事长、总经理：丁建文先生 董事、副总经理：林常青先生 独立董事：张颖先生 董事会秘书：袁绘杰先生 投资者可于 2025 年 11 月 17 日 （星期一） 至 11 月 21 日 （星期五）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司投资者关系邮箱 aveir@c-ave.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 爱威科技股份有 ...

Core Viewpoint - Aiwei Technology (688067.SH) has received a medical institution practice license for its wholly-owned subsidiary, Hunan Aiwei Medical Laboratory Co., Ltd., allowing it to officially provide third-party medical testing services, which opens new business growth opportunities and integrates existing testing instruments and reagents with testing services into a "device + service" business model [1]. Company Summary - Hunan Aiwei Medical Laboratory Co., Ltd. has obtained the "Medical Institution Practice License" issued by the Health and Health Bureau of Hunan Xiangjiang New Area [1]. - The licensed diagnostic specialties include: medical laboratory, clinical body fluids and blood, clinical microbiology, clinical chemical testing, clinical immunology and serology, and clinical cellular molecular genetics [1]. - The new license enables the company to offer third-party medical testing services, enhancing its business model by integrating testing equipment and services [1].

Core Viewpoint - Aiwei Technology (688067.SH) has received a medical institution practice license for its wholly-owned subsidiary, Hunan Aiwei Medical Laboratory Co., Ltd, enabling it to provide third-party medical testing services, which will create new business growth opportunities and integrate existing testing instruments and reagents with testing services into a "device + service" business model [1] Group 1 - The company has obtained a medical institution practice license from the Hunan Xiangjiang New Area Health Bureau [1] - Hunan Aiwei Medical Laboratory Co., Ltd will officially offer third-party medical testing services [1] - This development is expected to open new business growth points for the company [1] Group 2 - The integration of existing testing instruments and reagents with testing services will enhance the company's offerings [1] - The company aims to create a comprehensive "device + service" business model [1]

Core Viewpoint - Aiwei Technology (688067.SH) has received a medical institution practice license for its wholly-owned subsidiary, Hunan Aiwei Medical Laboratory Co., Ltd, enabling it to officially provide third-party medical testing services [1] Group 1: Business Expansion - The acquisition of the medical institution practice license opens a new growth avenue for the company [1] - This development allows for the integration of existing testing instruments and reagent consumables with testing services, creating a "device + service" integrated business model [1]

Core Viewpoint - The company has received a medical institution practice license for its subsidiary, which will enable it to provide third-party medical testing services, thus creating new business growth opportunities and promoting an integrated "equipment + service" business model [1] Group 1 - The subsidiary, Hunan Aiwei Medical Testing Co., Ltd., has obtained a medical institution practice license from the Hunan Xiangjiang New Area Health and Health Bureau [1] - The license is valid from November 4, 2025, to November 3, 2030, for the facility named Changsha Aiwei Medical Testing Laboratory [1] - The acquisition of this license will allow the company to officially offer third-party medical testing services [1]

Core Viewpoint - The medical device sector experienced a slight decline of 0.31% on November 6, with Danaher Biomedical leading the losses, while the overall market indices showed gains, with the Shanghai Composite Index up by 0.97% and the Shenzhen Component Index up by 1.73% [1][2]. Group 1: Market Performance - The Shanghai Composite Index closed at 4007.76, increasing by 0.97% [1]. - The Shenzhen Component Index closed at 13452.42, increasing by 1.73% [1]. - The medical device sector saw a net outflow of 638 million yuan from major funds, while retail investors contributed a net inflow of 446 million yuan [2][3]. Group 2: Individual Stock Performance - Hualan Co., Ltd. (301093) saw a significant increase of 8.53%, closing at 44.00 yuan with a trading volume of 67,500 shares and a transaction value of 293 million yuan [1]. - Danaher Biomedical (920009) led the declines with a drop of 4.69%, closing at 83.50 yuan and a trading volume of 24,900 shares, resulting in a transaction value of 206 million yuan [2]. - Other notable gainers included Furuida (300049) with a 4.32% increase and a closing price of 74.56 yuan, and Kangzhong Medical (688607) with a 3.04% increase, closing at 29.81 yuan [1][2]. Group 3: Fund Flow Analysis - Major funds showed a net outflow in several stocks, including Furuida with a net outflow of 23.99 million yuan, while retail investors showed a net inflow of 25.27 million yuan [3]. - Dongfulong (300171) experienced a net inflow of 21.17 million yuan from major funds, indicating positive sentiment towards the stock [3]. - The overall trend indicates a mixed sentiment in the medical device sector, with some stocks attracting retail interest despite the overall outflow from major funds [2][3].

Group 1 - The core transaction on November 4 involved a block trade of 110,000 shares of Aiwei Technology, with a transaction value of 3.0558 million yuan, at a price of 27.78 yuan, which represents a discount of 4.50% compared to the closing price of the day [2][3] - The buyer of the block trade was Guohai Securities Co., Ltd. Shandong Branch, while the seller was Guolian Minsheng Securities Co., Ltd. Beijing Jiancai City West Road Securities Branch [2][3] - Over the past three months, Aiwei Technology has recorded a total of 8 block trades, amounting to a cumulative transaction value of 28.3489 million yuan [2] Group 2 - The closing price of Aiwei Technology on the day of the transaction was 29.09 yuan, reflecting an increase of 0.73%, with a turnover rate of 2.82% and a total transaction amount of 55.5318 million yuan [2] - The net inflow of main funds for the day was 287,500 yuan, and over the past five days, the stock has increased by 2.83% with a total net inflow of 564,800 yuan [2] - The latest margin financing balance for Aiwei Technology is 41.5318 million yuan, which has decreased by 2.2129 million yuan over the past five days, representing a decline of 5.06% [3]

Group 1 - The core point of the news is that Awei Technology conducted a block trade on November 4, with a total of 110,000 shares traded, amounting to 3.0558 million yuan, which represents 5.22% of the total trading volume for the day [1][2] - The transaction price was 27.78 yuan, which is a discount of 4.5% compared to the market closing price of 29.09 yuan [1][2]

Group 1 - The core transaction on November 3 involved a block trade of 110,000 shares of Aiwei Technology, with a transaction value of 3.0338 million yuan, at a price of 27.58 yuan, which represents a discount of 4.50% compared to the closing price of the day [2][4] - Over the past three months, Aiwei Technology has recorded a total of 7 block trades, amounting to a cumulative transaction value of 25.2931 million yuan [3] - The closing price of Aiwei Technology on the day of the transaction was 28.88 yuan, reflecting an increase of 0.98%, with a daily turnover rate of 2.87% and a total transaction amount of 56.1045 million yuan [3] Group 2 - The latest margin financing balance for Aiwei Technology is 41.165 million yuan, which has increased by 1.5532 million yuan over the past five days, representing a growth rate of 3.92% [4] - Aiwei Technology was established on March 16, 2000, with a registered capital of 68 million yuan [4]

Core Viewpoint - Aivi Technology's stock closed at 28.88 yuan on November 3, with a slight increase of 0.98% and a notable block trade occurring [1] Trading Activity - A block trade was executed involving 110,000 shares, totaling 3.0338 million yuan, with a transaction price of 27.58 yuan, reflecting a discount of 4.50% [1] - The buyer was Huaxin Securities' Shanghai Lujiazui branch, while the seller was Guolian Minsheng Securities' Beijing Jiancai City West Road branch [1] Recent Performance - Over the past three months, Aivi Technology has recorded a total of 7 block trades, amounting to 25.2931 million yuan [1] - In the last five trading days, the stock has increased by 2.59%, although there has been a net outflow of 5.996 million yuan in principal funds [1]